Rohto Pharmaceutical Co., Ltd. (RPHCF)
Market Closed
7 Aug, 20:00
OTC PINK 
$
15. 00
0
0%
$
3.43B Market Cap
- P/E Ratio
0.27% Div Yield
150 Volume
- Eps
$ 15
Previous Close Want to track RPHCF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
RPHCF closed Friday higher at $15, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, RPHCF stock lost -7.9755%.
RPHCF pays dividends to its shareholders, with the most recent payment made on Jun 12, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of $0.15838.
The last earnings report, released on May 19, 2026, missed the consensus estimates by -0.2477%. On average, the company has fell short of earnings expectations by -5.1259%, based on the last three reports.
Rohto Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Dec 29, 2022.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XMUN (EUR).
RPHCF Chart
People also search for
Rohto Pharmaceutical Co., Ltd. (RPHCF) FAQ
What is the stock price today?
The current price is $15.00.
On which exchange is it traded?
Rohto Pharmaceutical Co., Ltd. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is RPHCF.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.27%.
What is its market cap?
As of today, the market cap is 3.43B.
Has Rohto Pharmaceutical Co., Ltd. ever had a stock split?
Rohto Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Dec 29, 2022.
Rohto Pharmaceutical Co., Ltd. Profile
| Household Products Industry | Consumer Staples Sector | Mr. Yamada Kunio CEO | OTC PINK Exchange | JP3982400008 ISIN |
| Japan Country | 9,144 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Rohto Pharmaceutical Co.,Ltd., originally founded as Yamada Pharmaceutical in 1899, stands today as a global provider of pharmaceutical products, cosmetics, and functional foods. Headquartered in Osaka, Japan, the company has significantly broadened its scope of operations since its name change in September 1949. Operating worldwide, Rohto delivers a diverse range of health and beauty products and services. It has successfully expanded its portfolio to include over-the-counter (OTC) pharmaceuticals, skincare items, and even contract development and manufacturing services. Further, Rohto contributes to the healthcare field through manufacturing diagnostic reagents and offering investment management services.
Products and Services
- Eye Care Products: Rohto manufactures a variety of eye care solutions, including eye drops for relief and hydration, products tailored for contact lens users, and eye washes for cleansing and comfort.
- Facial Care Products: The company's facial care range encompasses face washes, lotions, and creams designed to nourish and protect the skin, catering to different skin types and concerns.
- Medicine and Medicated Products: Offering treatments for skin ailments, Rohto also produces lip balms, sunscreens, and functional cosmetics to enhance skin health. Additionally, it provides medicines for internal conditions like digestive issues through herbal remedies.
- Regenerative Medicines: In the cutting-edge area of regenerative medicine, Rohto is exploring new treatments designed to restore function and structure to damaged tissues and organs.
- OTC Pharmaceutical Products: The company's OTC portfolio includes a wide range of products covering ophthalmic care, dermatological treatments, gastrointestinal remedies, diagnostic drugs, Chinese herbal medicines, and nutritional supplements.
- Beauty and Health Services: Rohto operates beauty counters offering professional beauty and health consultations, catering to customers' individual needs.
- Diagnostic Reagents: Beyond pharmaceuticals and cosmetics, Rohto manufactures diagnostic reagents, contributing to medical diagnostics and research.
- Contract Development and Manufacturing: Rohto provides contract services for the development and manufacturing of pharmaceutical and cosmetic products, leveraging its expansive knowledge and infrastructure to assist other businesses in the sector.
- Investment Management Services: Demonstrating its versatile business approach, Rohto also engages in investment management, supporting startups and innovations within the healthcare and beauty industries.
Contact Information
Address: 1-8-1 Tatsuminishi
Phone: 81 6 6758 1231
Website: https://www.rohto.co.jp
